Crossmark

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

Crossref DOI link: https://doi.org/10.1186/s12968-018-0478-3

Published Print: 2018-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ridouani, Fourat http://orcid.org/0000-0003-2582-464X
Damy, Thibaud

Tacher, Vania

Derbel, Haytham

Legou, François

Sifaoui, Islem

Audureau, Etienne

Bodez, Diane

Rahmouni, Alain

Deux, Jean-François
Funding

Funding for this research was provided by:

ARIM
License Information

Text and Data Mining valid from 2018-02-01

Text and Data Mining valid from 2018-02-01

Version of Record valid from 2018-08-16
More Information

This article is maintained by: Elsevier

Article Title: Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

Journal Title: Journal of Cardiovascular Magnetic Resonance

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s12968-018-0478-3

Content Type: article

Copyright: Copyright © 2018 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance